C07K 14/255
Salmonella
Official title: Salmonella (G)
C07K14/255 (Salmonella) appears on 246 US grants and 322 published applications in this corpus.
Search patents in C07K- Granted patents
- 246
- Published applications
- 322
- Assignees
- 198
- Inventors
- 605
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 3 | 0 |
| 1995 | 4 | 0 |
| 1996 | 4 | 0 |
| 1997 | 9 | 0 |
| 1998 | 6 | 0 |
| 1999 | 6 | 0 |
| 2000 | 4 | 0 |
| 2001 | 3 | 1 |
| 2002 | 8 | 8 |
| 2003 | 2 | 10 |
| 2004 | 3 | 11 |
| 2005 | 9 | 12 |
| 2006 | 5 | 14 |
| 2007 | 6 | 7 |
| 2008 | 6 | 6 |
| 2009 | 3 | 9 |
| 2010 | 8 | 14 |
| 2011 | 7 | 17 |
| 2012 | 8 | 8 |
| 2013 | 9 | 11 |
| 2014 | 10 | 15 |
| 2015 | 15 | 18 |
| 2016 | 12 | 15 |
| 2017 | 8 | 17 |
| 2018 | 16 | 14 |
| 2019 | 14 | 13 |
| 2020 | 9 | 13 |
| 2021 | 8 | 16 |
| 2022 | 8 | 16 |
| 2023 | 9 | 13 |
| 2024 | 2 | 11 |
| 2025 | 9 | 13 |
| 2026 | 4 | 20 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Klebsiella vaccine and methods of use11 Aug 2026US 12,702,704 B2Cornell University
- Compositions and methods of treatment comprising tumor-targeting bacteria and chemotherapy or immunotherapy agent9 Jun 2026US 12,648,970 B2The Curators of the University of Missouri
- Chimeric protein toxins for expression by therapeutic bacteria2 Jun 2026US 12,642,873 B1
- Recombinant strains and medium formulation for enhancing secretion titer using a type III secretion system3 Mar 2026US 12,565,519 B2Northwestern University
- Polypeptides self-assembling into nanoparticles9 Sep 2025US 12,410,213 B2Eth ZëRich
- Recombinant expression vector for catalase secretion and escherichia coli strain transformed therewith8 Oct 2026US 2026/0308603 A1The Industry & Academic Cooperation in Chungnam National University (IAC)
- A broadly protective prophylactic vaccine against pseudomonas aeruginosa24 Sep 2026US 2026/0284172 A1University of Kansas
- Contractile injection system and use thereof20 Aug 2026US 2026/0242806 A1
- Methods for producing high-level squalene6 Aug 2026US 2026/0226485 A1Massachusetts Institute of Technology
- Methods and constructs for improving conjugation efficiency30 Jul 2026US 2026/0218209 A1Ramot at Tel-Aviv University Ltd.
Most cited
By later US patents
- Avirulent microbes and uses therefor: Salmonella typhi109US 5,387,744 AWashington University · 1995
- Avirulent microbes and uses therefor: salmonella typhi103US 5,294,441 AWashington University · 1994
- Vaccines containing avirulent phop-type microorganisms101US 5,424,065 AWashington University · 1995
- Novel non-reverting shigella live vaccines87US 5,077,044 AThe Board of Trustees of the Leland Stanford Jr. University · 1991
- Genetically modified tumor-targeted bacteria with reduced virulence85US 6,080,849 AVion Pharmaceuticals, Inc. · 2000